Boston Scientific has launched the LUX-Dx Insertable Cardiac Monitor (ICM) System, a long-term diagnostic device inserted under the skin of patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope, in Europe.
Lydia Bradley, CRM service lead physiologist & ACP at Royal Wolverhampton Hospitals NHS Trust, England, said: “We had the opportunity to be one of the first in the UK to implant the LUX-Dx ICM. Signals seen so far at implant have been providing great sensing and amplitude of P waves as well as fibrillation waves. Patients have been happy and confident with the ease of setup and use of their patient phone. Ease of use, clarity of the information and intuitive platform are invaluable in helping us make prompt decisions.”
Read the full article here: www.med-technews.com